Skip to content
healthcare.dev

TADALAFIL

NDC 68788-4018, TADALAFIL, tablet, from Preferred Pharmaceuticals Inc..

Product NDC
68788-4018
Status
Listed
Labeler
Preferred Pharmaceuticals Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA211839
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68788-4018 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TADALAFIL5 mg/1

Pharmacologic classes

Phosphodiesterase 5 Inhibitor [EPC]; Phosphodiesterase 5 Inhibitors [MoA]

Package NDCNDC-11Package
68788-4018-16878840180115 TABLET in 1 BOTTLE (68788-4018-1)
68788-4018-26878840180220 TABLET in 1 BOTTLE (68788-4018-2)
68788-4018-36878840180330 TABLET in 1 BOTTLE (68788-4018-3)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/f9e9a953-2802-4bb1-91a3-a29be347801e

Use it

Look up 68788-4018 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68788-4018 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68788-4018. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.